Literature DB >> 30372552

Pediatric Bone Mineral Accrual Z-Score Calculation Equations and Their Application in Childhood Disease.

Andrea Kelly1, Justine Shults1, Sogol Mostoufi-Moab1, Shana E McCormack1, Virginia A Stallings1, Joan I Schall1, Heidi J Kalkwarf2, Joan M Lappe3, Vicente Gilsanz4, Sharon E Oberfield5, John A Shepherd6, Karen K Winer7, Mary B Leonard1,8, Babette S Zemel1.   

Abstract

Annual gains in BMC and areal bone mineral density (aBMD) in children vary with age, pubertal status, height-velocity, and lean body mass accrual (LBM velocity). Evaluating bone accrual in children with bone health-threatening conditions requires consideration of these determinants. The objective of this study was to develop prediction equations for calculating BMC/aBMD velocity SD scores (velocity-Z) and to evaluate bone accrual in youth with health conditions. Bone and body compositions via DXA were obtained for up to six annual intervals in healthy youth (n = 2014) enrolled in the Bone Mineral Density in Childhood Study (BMDCS) . Longitudinal statistical methods were used to develop sex- and pubertal-status-specific reference equations for calculating velocity-Z for total body less head-BMC and lumbar spine (LS), total hip (TotHip), femoral neck, and 1/3-radius aBMD. Equations accounted for (1) height velocity, (2) height velocity and weight velocity, or (3) height velocity and LBM velocity. These equations were then applied to observational, single-center, 12-month longitudinal data from youth with cystic fibrosis (CF; n = 65), acute lymphoblastic leukemia (ALL) survivors (n = 45), or Crohn disease (CD) initiating infliximab (n = 72). Associations between BMC/aBMD-Z change (conventional pediatric bone health monitoring method) and BMC/aBMD velocity-Z were assessed. The BMC/aBMD velocity-Z for CF, ALL, and CD was compared with BMDCS. Annual changes in the BMC/aBMD-Z and the BMC/aBMD velocity-Z were strongly correlated, but not equivalent; LS aBMD-Z = 1 equated with LS aBMD velocity-Z = -3. In CF, BMC/aBMD velocity-Z was normal. In posttherapy ALL, BMC/aBMD velocity-Z was increased, particularly at TotHip (1.01 [-.047; 1.7], p < 0.0001). In CD, BMC/aBMD velocity-Z was increased at all skeletal sites. LBM-velocity adjustment attenuated these increases (eg, TotHip aBMD velocity-Z: 1.13 [0.004; 2.34] versus 1.52 [0.3; 2.85], p < 0.0001). Methods for quantifying the BMC/aBMD velocity that account for maturation and body composition changes provide a framework for evaluating childhood bone accretion and may provide insight into mechanisms contributing to altered accrual in chronic childhood conditions.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  ACUTE LYMPHOBLASTIC LEUKEMIA; BONE ACCRUAL/ACCRETION; BONE MINERAL CONTENT/DENSITY; CROHN'S DISEASE; CYSTIC FIBROSIS; GROWTH; LEAN BODY MASS; PEDIATRIC ENDOCRINOLOGY; PUBERTY

Mesh:

Year:  2018        PMID: 30372552     DOI: 10.1002/jbmr.3589

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

Review 1.  [Fractures and bone mineral density in childhood].

Authors:  Christine Hofmann; Herrmann Girschick; Constantin Lapa; Oliver Semler; Franz Jakob
Journal:  Z Rheumatol       Date:  2019-09       Impact factor: 1.372

Review 2.  Dual-energy X-ray absorptiometry bone densitometry in pediatrics: a practical review and update.

Authors:  Hedieh Khalatbari; Larry A Binkovitz; Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2020-08-28

3.  Poor Glycemic Control Is Associated With Impaired Bone Accrual in the Year Following a Diagnosis of Type 1 Diabetes.

Authors:  David R Weber; Rebecca J Gordon; Jennifer C Kelley; Mary B Leonard; Steven M Willi; Jacquelyn Hatch-Stein; Andrea Kelly; Oksana Kosacci; Olena Kucheruk; Mirna Kaafarani; Babette S Zemel
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

4.  A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents.

Authors:  Leanne M Ward; David R Weber; Craig F Munns; Wolfgang Högler; Babette S Zemel
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

5.  The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis.

Authors:  Melissa S Putman; Logan B Greenblatt; Michael Bruce; Taisha Joseph; Hang Lee; Gregory Sawicki; Ahmet Uluer; Leonard Sicilian; Isabel Neuringer; Catherine M Gordon; Mary L Bouxsein; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

Review 6.  Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.

Authors:  Leanne M Ward
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-16       Impact factor: 5.555

7.  An update on methods for assessing bone quality and health in Cystic fibrosis.

Authors:  Kristen M Williams; Amy Darukhanavala; Rebecca Hicks; Andrea Kelly
Journal:  J Clin Transl Endocrinol       Date:  2021-12-06

8.  Bone accrual and structural changes over one year in youth with cystic fibrosis.

Authors:  Rosara M Bass; Babette S Zemel; Virginia A Stallings; Mary B Leonard; Jaime Tsao; Andrea Kelly
Journal:  J Clin Transl Endocrinol       Date:  2022-03-25

Review 9.  Part I: Which Child with a Chronic Disease Needs Bone Health Monitoring?

Authors:  Leanne M Ward
Journal:  Curr Osteoporos Rep       Date:  2021-07-10       Impact factor: 5.096

Review 10.  Evolutionary Perspectives on the Developing Skeleton and Implications for Lifelong Health.

Authors:  Alexandra E Kralick; Babette S Zemel
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-04       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.